Structural Peptide Complementation for Bioluminescent Interaction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies lack sensitive tools to detect and monitor molecular interactions under physiological conditions, particularly at normal expression levels, necessitating improved methods for high-sensitivity detection of protein interactions.
Innovation Solution
The development of bioluminescent complexes formed by complementary non-luminescent peptides and polypeptides that assemble into a bioluminescent state upon association, allowing for the detection of molecular interactions through light emission.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional detection methods are used to monitor molecular interactions, then the detection can be performed under physiological conditions, but the sensitivity is insufficient for normal expression levels
Solution Approach 1:
The invention divides a luminescent protein into multiple separate peptide fragments (first peptide, second peptide, third peptide) that individually lack luminescent activity. These segments are expressed separately under physiological conditions and only assemble into a functional luminescent complex when the target protein interaction occurs, thereby achieving high detection sensitivity without compromising reliability under physiological conditions.
Solution Approach 2:
The invention changes the luminescent state parameter by controlling the assembly of peptide fragments. The peptides transition from a non-luminescent state when separate to a luminescent state when assembled into the complete complex, providing a sensitive optical signal that reflects the occurrence and strength of molecular interactions under physiological conditions.
2Measurement precision
If luminescent proteins are used directly for detection, then high sensitivity can be achieved, but the system complexity increases and physiological compatibility decreases
Solution Approach 1:
Instead of using a complete luminescent protein which would increase system complexity, the invention segments the protein into multiple simple peptide fragments that can be easily synthesized and expressed. These fragments only gain luminescent functionality when assembled together through specific protein interactions, thereby maintaining system simplicity while achieving high detection sensitivity.
Solution Approach 2:
The peptide fragments act as intermediaries between the target protein interaction and the luminescent signal. The fragments are designed to assemble into a luminescent complex only when brought together by the specific interaction of interest, providing a indirect but sensitive readout that reduces system complexity while maintaining detection capability.
3Device complexity
If non-luminescent peptides are used separately, then the system remains simple and physiologically compatible, but no detectable signal is generated
Solution Approach 1:
The invention combines multiple non-luminescent peptide fragments into a single luminescent complex through structural complementation. When the peptides assemble together driven by specific protein interactions, their combined structure creates luminescent activity that was absent in the individual fragments, thereby generating a detectable signal while maintaining system simplicity and physiological compatibility.
Solution Approach 2:
The invention exploits parameter change in luminescent activity by controlling peptide assembly. The peptides transition from a non-luminescent parameter state when separate to a luminescent parameter state when assembled, providing a sensitive optical signal that reflects molecular interactions without increasing system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-sensitivity detection of molecular interactions by correlating the formation of bioluminescent complexes, providing a proportional bioluminescent signal based on interaction strength and stability.
Implementation Method 1
bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide
Implementation Method 2
the assembled pair catalyzes a chemical reaction of an appropriate substrate into a high energy state, and light is emitted
Data Source
AI summary
Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.